CX50 Diagnostic Ultrasound System, Sparq Diagnostic Ultrasound System— 510(k) K162329
Substantially EquivalentPhilips Health Care
FDA 510(k) clearance K162329 for CX50 Diagnostic Ultrasound System, Sparq Diagnostic Ultrasound System, Substantially Equivalent on 2016-09-14. Applicant: Philips Health Care. Device class: 2.
Clearance details
- Applicant
- Philips Health Care
- Product code
- Product code IYN
- Device class
- Class 2
- Regulation
- 21 CFR 892.1550
- Advisory panel
- Radiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Bothell, WA, US
Recent devices under product code IYN
view all- K261585 — Diagnostic Ultrasound System (Nuewa A20W) +10 more
- K261617 — Diagnostic Ultrasound System (11+ models)
- K263150 — V10 Diagnostic Ultrasound System +10 more
- K261933 — Voluson Expert 18; Voluson Expert 20; Voluson Expert 22
- K262548 — EPIQ Inspira Series Diagnostic Ultrasound System; Affiniti Series Diagnostic Ultrasound System
More clearances from Philips Health Care
view allAdverse events under product code IYN
product code IYN- Death
- 25
- Injury
- 163
- Malfunction
- 1,538
- Other
- 4
- Total
- 1,730
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Recalls naming K162329
K-number listed on FDA's recall record- Z-2361-2025 — C9-3io Transducer Probe
- Z-2370-2025 — L10-4LAP Transducer Probe
- Z-1841-2020 — Transducer S7-3t UDI (01)00884838061439 REF 989605406772 Can be used with: CX50, EPIQ 7, Affiniti 50 and Affiniti 70 Ultrasound systems - Product Usage: Diagnostic ultrasound imaging or fluid flow analysis of the human body - particularly transesophageal echocardiography (TEE) studies
Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K162329.
Data sourced from openFDA. This site is unofficial and independent of the FDA.